PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
PDS Biotechnology (PDSB) Tops Q3 EPS by 10c
November 14, 2023 7:33 AM ESTPDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
... More


